Regulatory Affairs Specialist H-1B Sponsorship: Pharma and MedTech Salary Reality 2026

Regulatory affairs roles at pharma and MedTech companies actively sponsor H-1B, but the 2026 wage-weighted lottery changes what compensation level you need to maximize your selection odds.

You spent years studying pharmaceutical sciences, biochemistry, or a related life-sciences discipline, and you know that regulatory affairs is one of the clearest paths from an advanced degree to a stable, well-compensated career in the US pharma and MedTech industry. The complication you keep running into is whether employers will actually sponsor your H-1B — and whether, in the 2026 lottery environment, the offer you're negotiating puts you in a competitive position to be selected.

The short answer is yes, regulatory affairs does sponsor, and yes, the wage level of your offer now matters more than ever. This guide gives you the precise mechanics — the 2026 lottery change that reshapes your strategy, the salary reality across pharma and MedTech, the specialty-occupation analysis, the green card path, and the common mistakes that cost candidates offers or petitions they should have won.

Why regulatory affairs is a strong H-1B category

Regulatory affairs specialists sit at the intersection of scientific expertise and legal compliance. You're responsible for FDA submissions (INDs, NDAs, BLAs, 510(k)s, PMAs), CMC documentation, labeling, post-market surveillance, and interactions with regulators in the US and often internationally (EMA, PMDA, Health Canada). The work is highly specialized and requires deep knowledge of 21 CFR Parts 210, 211, 312, 314, 601, and 820, depending on whether your company focuses on drugs, biologics, or devices.

That specialization is exactly what makes the H-1B specialty-occupation standard achievable. USCIS defines a specialty occupation as one requiring theoretical and practical application of highly specialized knowledge, and attainment of a bachelor's degree or higher in a specific field. A regulatory affairs role tied to FDA drug submissions needs a life sciences, pharmacy, or chemistry background — that nexus is documentable and defensible. Employers including large integrated pharma companies, contract research organizations (CROs), and medical device manufacturers file and win these petitions regularly.

If you've been worried that regulatory affairs is somehow a gray area for H-1B, it is not. The challenge is the lottery, the wage level, and the employer's willingness to go through the process — not the specialty-occupation test itself.

The 2026 lottery change and what it means for your compensation strategy

The single most important development for your H-1B timing in 2026 is the wage-weighted lottery, effective February 27, 2026. Under this system, USCIS does not draw registrations randomly across all petitions. Instead, registrations are ranked by DOL prevailing wage level before random selection occurs within each tier.

The projected selection rates vary significantly by level:

These are projections, not guarantees — the actual rate depends on registration volume for that cap year — but the directional difference is stark. A Level III registration is roughly three times as likely to be selected as a Level I registration at the same employer.

For regulatory affairs candidates, this creates a concrete negotiating lever. If your offer letter lands you at Level II and the employer can document experience and responsibilities that justify Level III, you and your employer both benefit from structuring the compensation and job description to reach that threshold. The relevant occupational wage data comes from the DOL's Foreign Labor Certification Data Center, using the correct Standard Occupational Classification (SOC) code for your role.

Separately, the DOL proposed a 21–33% increase in prevailing wage floors in March 2026. This rule is still proposed as of mid-2026, not yet final. If finalized, it would raise the minimum salary required to file at each wage level for H-1B petitions — which could affect offer negotiations and employer willingness at the margins. Confirm the current status with your immigration attorney; do not base final offer decisions on this proposal without checking whether it has been finalized and what the effective date is.

For more on how pharma companies structure H-1B sponsorship broadly, see our pharmaceutical industry visa sponsorship guide.

Salary landscape for regulatory affairs in pharma and MedTech

Salary ranges in regulatory affairs vary significantly by sub-sector, seniority, geography, and company type. The table below reflects general market positioning as of 2026 — these are illustrative ranges drawn from observable market data, not guarantees for any specific role.

Metro matters. San Francisco Bay Area, Boston/Cambridge, and New Jersey pharma corridor roles tend to sit at the higher end of these bands. Research Triangle Park (North Carolina), Philadelphia, and Chicago typically fall in the middle. Smaller markets and CROs often track lower.

The reason wage level strategy matters practically is this: in the Boston or New Jersey pharma corridor, a mid-level regulatory affairs specialist offer may naturally reach Level III under the local wage data. In a lower-cost market, the same title at a smaller employer may land at Level II. Understanding where your specific offer lands — before you accept — is worthwhile analysis given the lottery stakes.

Specialty occupation documentation checklist

Your employer's immigration attorney will build the I-129 petition. You can help by ensuring these elements are documented clearly:

1. Degree requirement in the job description. The posting and internal requisition should require a bachelor's degree or higher in a specific scientific field (pharmaceutical sciences, chemistry, biochemistry, biology, or a closely related discipline), not just "a bachelor's degree in any field."
2. Duties tied to the degree. The petition should explain how each core duty requires the theoretical and practical knowledge acquired in the scientific degree program. FDA submission strategy, CTD (Common Technical Document) preparation, and CMC review are examples of duties that directly invoke specialized knowledge.
3. Industry standard evidence. Your attorney may include industry surveys or professional organization guidance showing that regulatory affairs roles customarily require the specific degree type.
4. Your credentials. Transcripts, any RAC (Regulatory Affairs Certification from RAPS — the Regulatory Affairs Professionals Society), prior H-1B approvals in the field, and publications or conference presentations all strengthen the petition.

If you receive an RFE on specialty occupation, it typically questions whether the degree requirement is genuinely necessary or whether the role could be performed without it. The response should provide additional evidence tying the scientific degree to specific regulatory decision-making tasks.

The Labor Condition Application and wage compliance

Before USCIS can adjudicate the H-1B petition, your employer files a Labor Condition Application (LCA) with the DOL. The LCA certifies that you will be paid at least the prevailing wage for the occupational category in the geographic area of intended employment, and that employing you will not adversely affect wages and working conditions of US workers in similar roles.

For regulatory affairs, the correct SOC code matters — a mismatch between the LCA occupational code and the actual duties is a source of RFEs and compliance risk. Work with your employer to confirm which SOC code most precisely describes your role. Common options include 13-1041 (Compliance Officers) and 19-1041 (Medical Scientists) depending on how your duties are structured. Some employers use 29-2011 (Medical and Clinical Laboratory Technologists) for device-adjacent roles, though this is a narrower fit.

The LCA must be posted at the worksite for ten business days, and a copy must be available for public inspection. If you change worksites substantially — relocating to a different Metropolitan Statistical Area — a new LCA and potentially an amended H-1B petition are required. Keep this in mind if your employer discusses remote or hybrid arrangements that span metro areas.

Cap-exempt options for regulatory affairs professionals

Not every regulatory affairs role goes through the lottery. If you can position yourself at a cap-exempt employer, you bypass the selection process entirely and can file any time of year.

Cap-exempt employers for regulatory affairs purposes include:

• Academic medical centers and university hospitals — Many run regulatory affairs offices supporting investigator-initiated IND applications, IRB-compliant clinical trials, and device studies. Roles here are genuine, and the employer files H-1B petitions outside the cap.
• Nonprofit research institutions — Some academic spinouts and independent research institutes qualify as cap-exempt entities.
• Government research organizations — Agencies like NIH have affiliated programs where H-1B can be filed cap-exempt.

The trade-off is that cap-exempt regulatory roles often pay below large pharma market rates, and the scope may be narrower. However, once you hold an approved H-1B from a cap-exempt employer, you can transfer to a cap-subject employer without re-entering the lottery — because transfers are inherently cap-exempt. This is the "cap-exempt bridge" strategy.

For a detailed breakdown of how this bridge approach works in 2026's weighted lottery environment, see our cap-exempt bridge strategy guide.

Your OPT and STEM OPT window

If you're currently on F-1 OPT, you have 12 months of work authorization after graduation. If your degree is in a STEM-designated field — which includes pharmaceutical sciences, biochemistry, chemistry, biology, biomedical engineering, and many adjacent disciplines — you can apply for a 24-month STEM OPT extension, giving you up to 36 months total.

During your OPT period, you face a 90-day cumulative unemployment limit. A gap between employers counts toward that limit, so active job searching should be structured to minimize any authorization gaps. Your employer also has obligations under the 24-month STEM extension: they must complete an I-983 training plan documenting your professional development goals, and there are quarterly attestation requirements.

The practical sequencing for most regulatory affairs candidates is:

1. Begin OPT upon graduation or program completion
2. Secure a regulatory affairs role that qualifies as STEM OPT-eligible
3. Apply for STEM OPT extension to extend work authorization
4. Your employer files H-1B registration in the March lottery window
5. If selected, file the full I-129 petition for October 1 start date
6. If not selected in the first lottery, you still have time for a second and potentially third attempt within the STEM OPT window

Three lottery chances on a standard path (two years of STEM OPT plus one overlap year) is a meaningful advantage. For a full breakdown of how the STEM OPT extension interacts with the 4-year admission rule and fixed admission dates, see our OPT to STEM OPT to H-1B sequencing guide.

The $100,000 supplemental fee — what it means for you

A White House proclamation imposed a $100,000 supplemental fee on certain new H-1B petitions. If you are an F-1 student already inside the United States who will change status to H-1B through a cap-subject petition, you are generally exempt from this fee. The fee applies to workers being brought from abroad on new cap-subject petitions.

This exemption matters because it means your employer's total H-1B filing cost is substantially lower for a domestic status change than for sponsoring someone from outside the US — which removes a cost-side objection some employers raise. When talking to a prospective sponsor about their willingness to file, it is worth clarifying that you are in the US on OPT and the $100,000 fee does not apply to your petition.

Always confirm your specific situation with your immigration attorney, as the fee rules have nuances and edge cases.

Green card path for regulatory affairs professionals

Regulatory affairs is a well-established green card sponsorship path at major pharma and MedTech companies. The standard route is PERM labor certification (EB-3) or, for candidates with advanced degrees or exceptional ability, EB-2. Some companies will explore EB-2 National Interest Waiver (NIW) self-petition for regulatory professionals with demonstrated research contributions or published work, though this is less common than in pure research roles.

If your country of birth is India or China, priority date backlogs in EB-2 and EB-3 are a material reality. Understanding the current priority date before accepting an offer — and asking your employer explicitly whether they support EB-1C (multinational manager) as a faster path after a few years — is prudent early-career planning. For a full analysis of the EB-2 and EB-3 India situation, see our EB-2 and EB-3 India priority date tracker.

For candidates whose work touches life sciences research broadly, our biotech and life sciences H-1B sponsorship overview covers the green card landscape across the sector.

Step-by-step timeline to H-1B for a regulatory affairs candidate

Here is a realistic end-to-end sequence for a candidate currently on F-1 OPT:

1. Month 1–3 after graduation: Start OPT. Begin applying to regulatory affairs roles with H-1B sponsorship track records.
2. Month 3–6: Secure offer. Confirm employer's H-1B sponsorship commitment in writing, including willingness to file at the appropriate wage level.
3. Month 6–12 (first year of OPT): Employer files STEM OPT extension application if applicable. You continue working under OPT.
4. January–March of first or second year: Employer submits H-1B registration during the USCIS registration window (typically mid-February to late March for the following October 1 cap year).
5. March: USCIS announces lottery selections. If selected, your employer has approximately 90 days to file the full I-129 petition.
6. April–June: I-129 petition filed. LCA already certified. Premium processing ($2,965 as of March 1, 2026) recommended for certainty within 15 business days.
7. October 1: H-1B status begins (or change-of-status takes effect if filing from inside the US).

If not selected in the first lottery, the STEM OPT window typically allows one or two additional attempts. Use the intervening time to pursue the wage level strategy — confirm that your compensation and job description support Level III or IV positioning for the next registration cycle.

Common mistakes

Accepting an entry-level offer without checking the wage level. In the wage-weighted lottery, a Level I registration is roughly one-third as likely to be selected as a Level III. Before accepting an offer, ask your employer which wage level the LCA will be filed at and whether there is room to structure the role — through seniority, specialization, or additional responsibilities — to reach Level II or III.

Ignoring the proposed DOL wage increase. The March 2026 proposed rule to raise prevailing wage floors by 21–33% is not yet final, but it could raise the minimum compensation required to file at each level. If your offer letter is drafted before the rule is finalized, and the rule takes effect before your petition is filed, your employer may need to issue an amended offer. Build this contingency into your offer conversation.

Treating all pharma companies as equivalent sponsors. Large integrated manufacturers (top 20 global pharma by revenue) have robust immigration infrastructure and consistent H-1B track records. Small pharma startups with ten employees and thin financials may have the intent to sponsor but lack the infrastructure — and a weak employer profile raises denial risk. Research the employer's H-1B history in the LCA disclosure data and USCIS employer data hub before accepting.

Not getting RAPS certification or equivalent credentials. The Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professionals Society is the industry's primary credential. While it is not required for H-1B specialty occupation, it strengthens the petition's argument that the role requires specialized knowledge, and it strengthens your candidacy in general.

Assuming remote work is a free variable. Remote work across Metropolitan Statistical Areas creates LCA and H-1B amendment complexity. If your employer is offering a fully remote role while headquartered in one metro and you plan to live in another, clarify how they will handle the LCA before accepting. This is solvable but requires proactive coordination.

Not asking about PERM timeline and green card support upfront. At the offer negotiation stage, asking "does this role include green card sponsorship?" is entirely reasonable. Some employers offer it only after a performance review period; others begin PERM within the first year. Knowing the answer early avoids the scenario where you realize two years in that green card support was assumed but never committed.

Frequently asked questions

Do regulatory affairs specialists qualify as H-1B specialty occupations?

Yes. Regulatory affairs roles at pharma, biotech, and MedTech companies consistently qualify as specialty occupations under USCIS standards. The position typically requires at minimum a bachelor's degree in life sciences, pharmacy, biochemistry, or a related scientific field. Employers routinely obtain H-1B approvals for these roles, and USCIS has recognized them as specialty occupations in prior adjudications. An RFE is possible if a job posting lists only a general bachelor's degree requirement, so work with your employer to ensure the petition ties duties specifically to the scientific degree field.

How does the wage-weighted H-1B lottery affect regulatory affairs candidates in 2026?

The wage-weighted lottery system effective February 27, 2026 ranks registrations by wage level before random selection. Regulatory affairs specialists at major pharma and MedTech firms often qualify at DOL Level III or Level IV due to seniority, specialization, or metro market rates. The projected Level III selection rate is approximately 45.9% versus roughly 15.3% for Level I registrations. This means pursuing a mid-to-senior level regulatory role — or negotiating a compensation package that reaches Level III — meaningfully increases your lottery odds over an entry-level offer at the same company.

What does the DOL proposed wage floor increase mean for my H-1B petition in 2026?

In March 2026, the Department of Labor proposed a 21 to 33 percent increase in prevailing wage floors for H-1B positions. If finalized, this would raise the minimum wage an employer must pay a sponsored regulatory affairs specialist at each DOL wage level. The practical effect is that sponsors would need to offer higher salaries to file at a given wage level, and some entry-level petitions currently filed at Level I may need to be upgraded. As of mid-2026 this rule is still proposed, not final — confirm the current status with your immigration attorney before accepting an offer tied to specific wage-level math.

Does the $100,000 H-1B supplemental fee apply to F-1 students changing status inside the US?

No. F-1 students who are already inside the United States and changing status to H-1B through a cap-subject petition are generally exempt from the $100,000 supplemental fee. The fee applies to new H-1B petitions for workers being brought from abroad. If you are on OPT or STEM OPT and your employer files a change-of-status petition for you, you fall in the exempt category under the White House proclamation guidance. Confirm this with your employer's immigration counsel, as the rule has nuances for certain situations.

Which pharma and MedTech companies reliably sponsor H-1B for regulatory affairs roles?

Large integrated pharmaceutical manufacturers, specialty pharma firms, contract research organizations, and major medical device companies have consistent track records of H-1B sponsorship for regulatory affairs staff. Cap-exempt employers such as academic medical centers and nonprofit research institutes also hire regulatory professionals and can file outside the lottery entirely. Searching the USCIS H-1B employer data hub and LCA disclosure data by SOC code 13-1041 (Compliance Officers) or 19-1099 (Life Scientists) helps identify companies that actively petition for these roles year after year.

Regulatory affairs is one of the more reliable H-1B sponsorship tracks in the life sciences — the roles are specialized, the employers are established, and the demand for credentialed professionals remains steady across pharma and MedTech. The 2026 changes shift the strategy from simply finding a sponsor to finding the right offer at the right wage level. Get that right, and your lottery odds are meaningfully better than the headlines suggest.

If you want a second set of eyes on your target company list, offer evaluation, or how to frame the sponsorship conversation in interviews, F1Jobs works with regulatory affairs candidates navigating exactly this process.